NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/08/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
CRYPTOMAP
ST13
US500000098748841Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Código do desenho
Tipo de titular
Localização do titular
Examinador
Localização atual
Titulares
Representantes
Scott D. Locke Dorf Nelson & Zauderer LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; chemicals, reagents and substances, being diagnostic reagents, buffers, nucleic acids, peptides, antibodies and immunological peptides for medical research; antibodies for scientific purposes; immunoassay reagents, other than for medical or veterinary use; diagnostic preparations and reagents for scientific or research use; test kits for scientific or research use composed primarily of nucleic acids, peptides, antibodies, buffers and reagents; proteins, namely, monoclonal and polyclonal antibodies, and immunological peptides for scientific or research use; nucleotides for scientific and research use
Classe 5
Pharmaceutical products and preparations for the treatment of cancer; pharmaceutical products and preparations for the prevention of cancer; vaccines; tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for regulating the immune system; immunoassay reagents for medical use; proteins with diagnostic and therapeutic uses, namely, protein arrays for medical diagnosis purposes; diagnostic reagents for medical use; diagnostic and testing preparations for clinical, medical and medical laboratory use, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in oncology and immunology testing for medical purposes; diagnostic test kits for medical purposes, namely, diagnostic kits comprising diagnostic agents, preparations and substances for medical use; antibodies for medical purposes; antigens for medical use; viral antigens for medical use; endogenous antigens for medical use; exogenous antigens for medical use
Classe 42
Research and development in the fields of medicine in the nature of oncology and immunology; scientific research for medical purposes in the field of oncology; mining in the field of biology; biological research services; pharmaceutical research services; analysis of human tissues for medical research; drug discovery services; provision of information and data on oncology and immunology; biomedical research services conducted using databases; consultancy, information and advisory services in the fields of oncology and immunology
Classe 44
Services in the field of oncology and immunology, namely, medical analysis services for the diagnosis of cancer and immunological disorders; medical screening services in the fields of oncology and immunology.
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/08/2025
REGISTERED-PRINCIPAL REGISTER
19/08/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2025
PUBLISHED FOR OPPOSITION
03/06/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/05/2025
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/05/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
25/04/2025
EXAMINER'S AMENDMENT ENTERED
25/04/2025
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/04/2025
EXAMINERS AMENDMENT E-MAILED
25/04/2025
EXAMINERS AMENDMENT -WRITTEN
25/04/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/04/2025
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/03/2025
NON-FINAL ACTION E-MAILED
21/03/2025
NON-FINAL ACTION WRITTEN
21/03/2025
ASSIGNED TO EXAMINER
13/03/2025
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/01/2025
NEW APPLICATION ENTERED
13/09/2024
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.